Alibaba Cloud Powered $1B of GMV in 68 Seconds, with Zero Downtime During 11.11
20.11.2019 05:00:00 EET | Business Wire | Press release
Alibaba Cloud today detailed the core technologies used during the record-breaking, 24-hour global shopping festival. The data intelligence backbone of Alibaba Group applied multiple mature innovations to power the cloud infrastructure and other key AI-enabled features, enabling millions of businesses to reach hundreds of millions of consumers worldwide.
Powerful cloud infrastructure supports extreme scalability and robustness
Launched during the Apsara Conference in September, the third generation of X-Dragon architecture fully supported the shopping event. The Elastic Bare Metal Servers improved cost efficiency by 20%. X-Dragon servers seamlessly integrate computing platforms, including the Elastic Compute Service (ECS) bare metal server and virtual machines, in a single architecture.
Tapping this strong foundation, Alibaba Cloud handled extreme scalability, processing USD1 billion of GMV (Gross Merchandise Volume) in the first 68 seconds of the event; volume hit USD10 billion of GMV in under 30 minutes. Overall, Alibaba Cloud’s infrastructure handled a record-shattering USD38.4 billion of GMV in 24 hours with zero downtime.
Combining advanced data processing and analytic capabilities with green technologies
Apsara Operating System processed around 970PB of data to support the peak performance of 544,000 orders per second, setting a record during 11.11.
POLARDB, a database developed by Alibaba Cloud, supported sales activity with a peak of 87 million requests processed per second. The new generation cloud-native POLARDB database combines performance with compatibility and availability of traditional enterprise databases in a cost-effective manner.
Through self-developed green technologies, including liquid immersion and deep-water cooling, power consumption for every 10,000 e-Commerce transactions can be reduced to 2kWh. Overall data center energy consumption dropped 70% from last year, saving over 200,000 kWh on 11.11.
AI-enabled features to empower sellers from international brands to SMBs
Thousands of Tmall merchants were upgraded to Tmall Flagship Store 2.0 storefronts before 11.11. Version 2.0 offers a unique user interface with a 3D Taobao avatar for customers to try on clothes and jewelry, further engaging customers via rich, interactive content and an omni-channel experience. The conversion rate per purchase was increased by over 20% from last year, serving 1,167 key brands' flagship stores this year.
Alime Shop Assistant, a customer-service chatbot supported by Alibaba DAMO Academy’s machine learning technologies, handled 97% of online customer inquiries on Alibaba’s e-commerce platforms Taobao and Tmall during 11.11. The virtual assistant also empowered hundreds of thousands of merchants on Alibaba’s platforms with intelligent customer services. For example, Alime answered questions during live broadcasts, extracting answers from pictures and responding conversationally. The Alime chatbot service offers 11 languages to support communications between global buyers and sellers.
Alibaba DAMO Academy provides enhanced machine translation technology for the cross-border e-commerce platform AliExpress. The technology can help small and medium-sized merchants globally to automatically translate their store and product pages into 21 languages, including Russian, Spanish, Turkish, French and Arabic, for buyers across Europe, Asia, America and the Middle East.
During the shopping festival, the machine translation service was used 1.66 billion times, with over 200 billion words translated in different languages.
Better consumer experience with live streaming and voice shopping
During this year’s global shopping festival, transactions during Taobao Live generated nearly USD 2.8 billion (RMB20 billion) in sales. More than half of the live streaming Tmall merchants selling products such as cosmetics, clothing, food, cars and electronics experienced robust growth, with home décor products seeing 400% sales growth.
This year, Taobao developed a new, real-time communications framework for audio and video on Alibaba Cloud. Network latency was reduced to 1.5 seconds from five to seven seconds, improving real-time interaction experience between broadcasters and users. Video AI identified products mentioned by broadcasters during live streaming, and audiences could view product links simultaneously displayed onscreen.
During 11.11, over one million orders were placed and processed through voice command via Tmall Genie, Alibaba A.I. Labs’ smart speaker. Purchased items during the day included 810,000 eggs, 1.4 million tons of rice and 76 tons of liquid detergent, a sign that voice shopping has become an increasingly popular trend among Chinese consumers of all ages.
About Alibaba Cloud
Established in 2009, Alibaba Cloud (www.alibabacloud.com), the data intelligence backbone of Alibaba Group, is among the world's top three IaaS providers, according to Gartner. It is also the largest provider of public cloud services in China, according to IDC. Alibaba Cloud provides a comprehensive suite of cloud computing services to businesses worldwide, including merchants doing business on Alibaba Group marketplaces, start-ups, corporations and public services. Alibaba Cloud is the official Cloud Services Partner of the International Olympic Committee.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191119005400/en/
Contact information
Alibaba Group
Claudia Ju claudia.ju@alibaba-inc.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom